BD (Becton, Dickinson and Company) is investing $110m to expand prefillable syringe production in the US. The investment will support the production of Neopak Glass Prefillable Syringes in Nebraska, with supply targeted to begin by mid-2026. The expansion will create approximately 120 new roles and enhance pharmaceutical supply chain resilience in the country. BD aims to support drug delivery innovation and supply chain resiliency as demand for biologics and combination products grows. This investment is part of BD’s plan to invest over $2.5bn in US manufacturing over five years, strengthening its American manufacturing footprint.

Read more at Yahoo Finance: BD invests $110m to expand US prefillable syringe production